MARKET

PRGO

PRGO

Perrigo Company
NYSE

Real-time Quotes | Nasdaq Last Sale

55.19
-0.53
-0.95%
Opening 12:14 09/18 EDT
OPEN
55.75
PREV CLOSE
55.72
HIGH
56.00
LOW
54.97
VOLUME
364.95K
TURNOVER
--
52 WEEK HIGH
75.42
52 WEEK LOW
36.28
MARKET CAP
7.51B
P/E (TTM)
86.03
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PRGO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 13 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PRGO News

  • Healthcare And Biotechnology Dashboard - Update
  • Seeking Alpha - Article.10h ago
  • Dividend Champion And Contender Highlights: Week Of September 15
  • Seeking Alpha - Article.3d ago
  • CenturyLink Stock Is Soaring. Here’s Why.
  • marketwatch.com.09/11 15:59
  • Why Is Perrigo (PRGO) Up 6.1% Since Last Earnings Report?
  • Zacks.09/07 13:30

More

Industry

Pharmaceuticals
-0.01%
Pharmaceuticals & Medical Research
-0.24%

Hot Stocks

Name
Price
%Change

About PRGO

Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare products and supplies infant formulas for the store brand market. It is also a provider of generic extended topical prescription products. The CHC segment is focused on the sale of OTC store brand products. The BCH segment develops, manufactures, markets and distributes various European OTC brands. The Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs. The Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri.
More

Webull offers Perrigo Company PLC (PRGO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.